Schering, Novartis develop blockbuster anti-cancer drug
26608
German and Swiss drug makers Schering and Novartis are developing a new anti-cancer drug with annual sales potential of up to two billion euros (2.7 billion dollars), Schering chief Hubertus Erlen said.
181860
Platforms have the potential to develop multiple drugs for a company.
432135
The Food and Drug Administration yesterday approved a cancer drug made by pharmaceutical giant Eli Lilly and Co. to treat advanced non-small cell lung cancer in patients who have undergone chemotherapy.
156434
An experimental cancer drug made by Abbott Laboratories Inc. passed its first round of human testing about six months faster than usual, thanks to a new program that aims to speed drug development.
106177
Lifestyle may play a big role in how well the latest generation of anti-cancer drugs works, research suggests.
191767
THURSDAY, Feb 10 (HealthDay News) -- A compound derived from a rare South American plant shows promise as a treatment for breast cancer, according to a University of Virginia Health System study.
374108
Drug giant Novartis AG says it will give its Cambridge neighbor, MIT, $65 million over 10 years to create a research program, likely to be the biggest in the world aimed at revolutionizing the way drugs are made.
188476
Its unique compound to fight the growth of cancer cells fails in trials.
238458
Seeking to improve its drug discovery technology and establish a beachhead in the fertile Cambridge biotechnology cluster, drug giant Schering-Plough Corp. of Kenilworth, N.J., said it would buy NeoGenesis Pharmaceuticals Inc. of Cambridge for an undisclosed sum.
240246
Swiss drugmaker Novartis AG's cancer-fighting drug Gleevec can still help treat chronic myeloid leukemia even after five years of use, a new study showed on Wednesday.
550498
German drug maker Schering AG was  boosted on Thursday as the U.S. Food and Drug Administration  granted its Bonefos treatment "priority review" for preventing  bone tumors in breast cancer patients.
32491
Novartis AG, Switzerland s biggest drugmaker, said third-quarter profit rose 21 percent as demand increased for the hypertension treatment Diovan and the cancer pill Gleevec.
667565
Novartis AG      won U.S. approval to  promote the drug Femara for women who have finished standard  therapy for early-stage breast cancer and run out of options,  the company said on Friday.
677142
Cancer cells often have a way of  outsmarting new targeted drug therapies, but U.S. researchers  said on Thursday a combination of targeted drugs could shut  down a tumor&#39;s backup plan, resulting in much more effective  treatments.
502607
Doctors are hopeful about a new drug to treat skin cancer by causing tumor cells to self-destruct by overloading them with oxygen
217395
Pfizer Inc's experimental oral biotechnology drug axitinib demonstrated substantial anti-tumor activity in patients with advanced thyroid cancer in a small, mid-stage clinical trial, according to data released at a major cancer meeting on Saturday.
519863
The company faces a pivotal clinical trial.